Collectively, these results indicate that SD55-H19 is more effective than SD55-EGFP in eliminating ICCA cells in vitro, and that its combination with BAY-4931 further enhances antitumor efficacy. The gene discussed is H19; the disease is infantile convulsions and choreoathetosis.